Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
10/2002
10/02/2002EP1244807A1 Il-6 like polynucleotide
10/02/2002EP1244790A2 Nucleic acids encoding polypeptides having chips activity
10/02/2002EP1244778A2 Human heparanase-related polypeptide and nucleic acid
10/02/2002EP1244702A2 A process for isolation of osteopontin from milk
10/02/2002EP1244700A2 Vesicle trafficking proteins
10/02/2002EP1244695A2 Extracellular matrix and cell adhesion proteins as well as genes encoding them
10/02/2002EP1244668A1 Purine derivatives, process for their preparation and use thereof
10/02/2002EP1244666A1 Imidazopyrimidinyl and imidazopyridinyl derivatives
10/02/2002EP1244664A1 Compounds and methods for the treatment of pain
10/02/2002EP1244661A1 Compounds and methods for the treatment of pain
10/02/2002EP1244657A2 Sulfonamides and derivatives thereof that modulate the activity of endothelin
10/02/2002EP1244654A1 Tetrahydrothiopy ranphthalazinone derivatives as pde4 inhibitors
10/02/2002EP1244653A1 Non peptide tachykinin receptor antagonists
10/02/2002EP1244649A1 Cyclic amp-specific phosphodiesterase inhibitors
10/02/2002EP1244647A1 Quinazoline derivatives as vegf inhibitors
10/02/2002EP1244643A1 Tryptase inhibitors
10/02/2002EP1244642A1 Substituted oxazoles and thiazoles derivatives as hppar alpha activators
10/02/2002EP1244640A1 Oxazolidinone derivatives
10/02/2002EP1244626A2 Caspase inhibitors and uses thereof
10/02/2002EP1244625A1 4-pyridinyl-n-acyl-l-phenylalanines
10/02/2002EP1244621A1 Nitrile derivatives as cathepsin k inhibitors
10/02/2002EP1244620A1 Cyclic amp-specific phosphodiesterase inhibitors
10/02/2002EP1244619A1 Pyrrolidines which inhibit camp-specific pde
10/02/2002EP1244616A1 (hetero)bicyclylmethanesulfonylamino-substituted hydroxamic acid derivatives
10/02/2002EP1244614A2 Tryptase inhibitors
10/02/2002EP1244471A1 Liquid composition of biodegradable block copolymer for drug delivery system and process for the preparation thereof
10/02/2002EP1244461A2 INHIBITION OF GSK-3$g(b)
10/02/2002EP1244450A1 8-aza-bicyclo[3.2.1]octane nmda/nr2b antagonists
10/02/2002EP1244441A1 Use of trimebutine for treating pain
10/02/2002EP1244440A1 Agonists specific for the peripheral cannabinoid receptor
10/02/2002EP1244356A1 Compositions and methods for l-nucleosides, l-nucleotides, and their analogs
10/02/2002EP0906279B1 Pyrrole derivatives
10/02/2002EP0841946B1 Methods for treatment of allergic asthma
10/02/2002DE10112926A1 Use of sugar phosphate or aminoacid having e.g. transaminase inhibiting activity, for treating tumors and/or sepsis or inducing immunosuppression
10/02/2002DE10112924A1 1-Butansäurederivate, pharmazeutische Zusammensetzungen enthaltend solche Derivate und Verwendungen solcher Derivate 1-butanoic acid derivatives, pharmaceutical compositions containing such derivatives and uses of such derivatives
10/02/2002DE10112825A1 HESylierung von Wirkstoffen in wässriger Lösung HESylation of drugs in aqueous solution
10/02/2002DE10108123A1 Wirkstoffkombination Combination of active ingredients
10/02/2002DE10108122A1 Arzneimittel auf Basis von Tramadol Medicines based on tramadol
10/02/2002CN1372594A OX2 receptor homologs
10/02/2002CN1372569A Keratinocyte growth factor-2
10/02/2002CN1372562A Imidazoimidazoles and triazoles as anti-inflammatory agents
10/02/2002CN1372559A Naphthyridine derivatives processes for their preparation their use and pharmaceutical compositions comprising them
10/02/2002CN1372557A Neurotrophin production/secretion promoting agent
10/02/2002CN1372555A Compositions and therapeutic mehtods involving isoflavones and analogues thereof
10/02/2002CN1372548A Heterocyclic compounds and medicinal use thereof
10/02/2002CN1372544A 新颖的维生素d类似物 Novel analogues of vitamin d
10/02/2002CN1372543A new vitamin derivatives with cyclic substructures in the side chains, method and intermediates for their production and their use in the preparation of medicaments
10/02/2002CN1372474A Methods for preventing or attenuating patthoangiogenic conditions
10/02/2002CN1371743A Songqi pain-stopping ointment
10/02/2002CN1371741A Chinese medicine injection for stopping cancer pain
10/02/2002CN1371739A Supplemented myrrh dragon's blood tablet formula and preparation process thereof
10/02/2002CN1371738A Amber anti-inflammatory pain-stopping powder medicine
10/02/2002CN1371728A Powder medicine for promoting blood circulation and removing blood stasis
10/02/2002CN1371727A Gastrodia tuber multi-function health care tea
10/02/2002CN1371722A Soft-extract for removing channel obstruction and relieving pain
10/02/2002CN1371720A Wind-removing pain-eliminating disinfecting soft extract
10/02/2002CN1371699A Chinese medicine liquid for treating rheumatism and preparation method thereof
10/02/2002CN1371686A Indomeizine external ointment for anti-inflammatory and stopping pain
10/02/2002CN1371683A Method for producing naproxen slow releasing capsule
10/02/2002CN1371680A Coculine osmosis pump type release-controlled preparation and preparation process thereof
10/02/2002CN1091612C Homothermal adhesive plaster promoting blood circulation to stop pain and preparation process thereof
10/02/2002CN1091611C Monosaccharidase analgesic oral liquor and preparation process thereof
10/02/2002CN1091609C Tincture for treating rheumatoid arthritis and its preparing process
10/02/2002CN1091606C Compound longshou soluble granules
10/02/2002CN1091597C Method for stabilizing pranoprofen and stable liquid preparation of pranoprofen
10/01/2002WO2001076630A1 Diagnostics and remedies for rheumatoid arthritis
10/01/2002US6459003 Ether compounds
10/01/2002US6458986 Intermediate for (R)-3-(4-Bromobenzyl)-1-(3,5-dichlorophenyl)-5-iodo-3-methyl-1-H-imidazo[1,2-α]imidazol-2-one
10/01/2002US6458934 Grafted complementarity determining regions to mouse monoclonal antibodies; amino acid replacements; autoimmune disease treatment and immunosuppressants; side effect reduction
10/01/2002US6458844 Antiinflammatory agents
10/01/2002US6458837 Lipophilic diesters of chelating agents
10/01/2002US6458830 The compounds are of particular use in the treatment or prevention of depression, anxiety, pain, inflammation, migraine, emesis and postherpetic neuralgia.
10/01/2002US6458829 Substituted γ-phenyl-Δ-lactones and analogs thereof and uses related thereto
10/01/2002US6458827 Adjustent of conformation equilibrium; active materials
10/01/2002US6458825 Eukaryotic cells contain multiple proteolytic systems, including lysosomal proteases, calpains, atp-ubiquitin-proteasome dependent pathway, and an
10/01/2002US6458822 2-oxo-imidazolidine-4-carboxylic acid hydroxamide compounds that inhibit matrix metalloproteinases
10/01/2002US6458814 Vitronectin receptor antagonists and are useful in the treatment of osteoporosis: treatment of inflammation, cancer and cardiovascular disorders, such as atherosclerosis and restenosis, and diseases wherein bone resorption is a factor,
10/01/2002US6458813 2-cyclohexyloxy-5-(2-chlorophenylcarbonylamino)pyridine, for example; treating inflammation, pain, diabetes, cancer
10/01/2002US6458810 Pharmaceutically active isoindoline derivatives
10/01/2002US6458805 Antagonists; especially sodium salts
10/01/2002US6458787 Novel pyrrolidine compounds that are potent and selective inhibitors of pde4, as well as methods of making the same, are disclosed. use of the compounds in the treatment of inflammatory diseases and other diseases involving elevated
10/01/2002US6458779 Treatment of conditions associated with excess production of soluble cd23 (s-cd23) such as autoimmune disease and allergy. the compounds of the invention are also inhibitors of the release of tumour necrosis factor (tnf).
10/01/2002US6458777 Methods and compositions for treating and preventing mucositis
10/01/2002US6458776 Inflammatory bowel disease
10/01/2002US6458575 Useful in the diagnosis, prevention, and treatment of cancer, autoimmune/inflammatory disorders, and reproductive disorders; screening libraries of peptides and antibodies; purification; amino acid sequences
10/01/2002US6458383 Pharmaceutical dosage form for oral administration of hydrophilic drugs, particularly low molecular weight heparin
10/01/2002US6458360 Soluble complement regulatory molecules
10/01/2002US6458353 Anti-CCR2 antibodies and methods of use therefor
10/01/2002US6458351 Yeast extracts
10/01/2002US6458338 Amino acid stabilized medicinal aerosol formulations
10/01/2002CA2404919A1 Diagnostic and therapeutic agents for rheumatoid arthritis
10/01/2002CA2245857C 1,4-dihydropyridine compounds as bradykinin antagonists
10/01/2002CA2228370C Piperazino derivatives as neurokinin antagonists
10/01/2002CA2174550C Suspension of loteprednol etabonate
10/01/2002CA2168113C Therapeutic peptide derivatives
10/01/2002CA2075358C Multimers of the soluble forms of tnf receptors, their preparation and pharmaceutical compositions containing them
09/2002
09/27/2002CA2378876A1 Cyclohexylamine derivatives as subtype selective n-methyl-d-aspartate antagonists
09/26/2002WO2002074981A2 Assays, methods and means relating to hypoxia inducible factor (hif) hydroxylase
09/26/2002WO2002074955A2 Oligonucleotides for regulating the gene coding for tnf$g(a) and/or genes controlled thereby and use thereof
09/26/2002WO2002074924A2 Method for measuring serine palmitoyltransferase in mammalian tissue and use thereof
1 ... 903 904 905 906 907 908 909 910 911 912 913 914 915 916 917 918 919 920 921 922 923 ... 1272